Costs and Treatment Patterns Among Patients with Atopic Dermatitis Using Advanced Therapies in the United States: Analysis of a Retrospective Claims Database
ConclusionsSwitching to combination therapy with SCSs and TCSs was common within 6 months of initiating advanced therapy in patients with AD. Patients also incurred significant pharmacy and outpatient costs. These results highlight the difficulty of managing AD with these existing treatment options.
Source: Dermatology and Therapy - Category: Dermatology Source Type: research
More News: Corticosteroid Therapy | Databases & Libraries | Dermatitis | Dermatology | Healthcare Costs | Methotrexate | Prednisone | Skin | USA Health